The concentration of 12-lipoxygenase in platelet rich plasma as an indication of cancer of the prostate

Wspolczesna Onkologia

Volumn 17, Issue 4, 2013, Pages 389-393

  Piotrowska, Małgorzata ^a   Szefel, Jarosław ^a,b   Skrzypczak Jankun, Ewa ^c   Łysiak Szydłowska, Wiesława ^d   Szajewski, Mariusz ^a,b   Aleksandrowicz Wrona, Ewa ^b   Jankun, Jerzy ^b,c  

^a Maritime Polish Red Cross Memorial Hospital   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d Powi lanski College Faculty of Health Science   (Poland)

Author keywords

12 lipoxygenase; Platelet rich plasma; Prostate cancer

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; C REACTIVE PROTEIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROSTATE CANCER; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THROMBOCYTE RICH PLASMA;

EID: 84886035503     PISSN: 14282526     EISSN: None     Source Type: Journal    
DOI: 10.5114/wo.2013.37221     Document Type: Article

References (28)

1. Dobrian AD, Lieb DC, Cole BK, Taylor-Fishwick DA, Chakrabarti SK, Nadler JL. Functional and pathological roles of the 12- and 15-lipoxygenases. Prog Lipid Res 2011; 50: 115-31.
2. Guo AM, Liu X, Al-Wahab Z, Maddippati KR, Ali-Fehmi R, Scicli AG, Munkarah AR. Role of 12-lipoxygenase in regulation of ovarian cancer cell proliferation and survival. Cancer Chemother Pharmacol 2011; 68: 1273-83.
3. Nie D, Che M, Grignon D, Tang K, Honn KV. Role of eicosanoids in prostate cancer progression. Cancer Metastasis Rev 2001; 20: 195- 206. (Pubitemid 34595268)
4. Matsuyama M, Yoshimura R, Mitsuhashi M, Tsuchida K, Takemoto Y, Kawahito Y, Sano H, Nakatani T. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway. Oncol Rep 2005; 14: 73-9.
5. Yoshimura R, Inoue K, Kawahito Y, Mitsuhashi M, Tsuchida K, Matsuyama M, Sano H, Nakatani T. Expression of 12-lipoxygenase in human renal cell carcinoma and growth prevention by its inhibitor. Int J Mol Med 2004; 13: 41-6.
6. Gohara A, Eltaki N, Sabry D, Murtagh D Jr, Jankun J, Selman SH, Skrzypczak-Jankun E. Human 5-, 12- and 15-lipoxygenase-1 coexist in kidney but show opposite trends and their balance changes in cancer. Oncol Rep 2012; 28: 1275-82.
7. Jiang WG, Douglas-Jones A, Mansel RE. Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer. Prostaglandins Leukot Essent Fatty Acids 2003; 69: 275-81. (Pubitemid 37463809)
8. Mohammad AM, Abdel HA, Abdel W, Ahmed AM, Wael T, Eiman G. Expression of cyclooxygenase-2 and 12-lipoxygenase in human breast cancer and their relationship with HER-2/neu and hormonal receptors: impact on prognosis and therapy. Indian J Cancer 2006; 43: 163-8.
9. Shappell SB, Manning S, Boeglin WE, et al. Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma. Neoplasia 2001; 3: 287-303. (Pubitemid 32801879)
10. Nie D, Nemeth J, Qiao Y, et al. Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase. Clin Exp Metastasis 2003; 20: 657-63. (Pubitemid 37463903)
11. Nie D, Hillman GG, Geddes T, Tang K, Pierson C, Grignon DJ, Honn KV. Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth. Cancer Res 1998; 58: 4047-51. (Pubitemid 28440552)
12. Krishnamoorthy S, Jin R, Cai Y, Maddipati KR, Nie D, Pagès G, Tucker SC, Honn KV. 12-Lipoxygenase and the regulation of hypoxiainducible factor in prostate cancer cells. Exp Cell Res 2010; 316: 1706-15.
13. Singh AK, Kant S, Parshad R, Banerjee N, Dey S. Evaluation of human LOX-12 as a serum marker for breast cancer. Biochem Biophys Res Commun 2011; 414: 304-8.
14. Nie D, Krishnamoorthy S, Jin R, et al. Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells. J Biol Chem 2006; 281: 18601-9. (Pubitemid 44035519)
15. Moreno JJ. New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development. Biochem Pharmacol 2009; 77: 1-10.
16. Pidgeon GP, Lysaght J, Krishnamoorthy S, Reynolds JV, O'Byrne K, Nie D, Honn KV. Lipoxygenase metabolism: roles in tumor progression and survival. Cancer Metastasis Rev 2007; 26: 503-24. (Pubitemid 350115127)
17. Wong BC, Wang WP, Cho CH, Fan XM, Lin MC, Kung HF, Lam SK. 12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells. Carcinogenesis 2001; 22: 1349-54. (Pubitemid 32898689)
18. Gao X, Grignon DJ, Chbihi T, et al. Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer. Urology 1995; 46: 227-37.
19. Nithipatikom K, Isbell MA, See WA, Campbell WB. Elevated 12- and 20-hydroxyeicosatetraenoic acid in urine of patients with prostatic diseases. Cancer Lett 2006; 233: 219-25. (Pubitemid 43327376)
20. McBride JA. Platelet adhesiveness: the effect of centrifugation on the measurement of adhesiveness in platelet-rich plasma. J Clin Pathol 1968; 21: 397-401.
21. Pidgeon GP, Kandouz M, Meram A, Honn KV. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. Cancer Res 2002; 62: 2721-7. (Pubitemid 34462758)
22. Leung HW, Yang WH, Lai MY, Lin CJ, Lee HZ. Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis. Food Chem Toxicol 2007; 45: 403-11. (Pubitemid 46188376)
23. Lovat PE, Oliverio S, RanalliM et al. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma. Cancer Res 2002; 62: 5158-67. (Pubitemid 35024586)
24. Aleem AM, Wells L, Jankun J, Walther M, Kühn H, Reinartz J, Skrzypczak-Jankun E. Human platelet 12-lipoxygenase: naturally occurring Q261/R261 variants and N544L mutant show altered activity but unaffected substrate binding and membrane association behavior. Int J Mol Med 2009; 24: 759-64.
25. Hickling S, Hung J, Knuiman M, Divitini M, Beilby J. Are the associations between diet and C-reactive protein independent of obesity? Prev Med 2008; 47: 71-6.
26. Yin B, Yang Y, Zhao Z, et al. Arachidonate 12-lipoxygenase may serve as a potential marker and therapeutic target for prostate cancer stem cells. Int J Oncol 2011; 38: 1041-6.
27. LaTulippe E, Satagopan J, Smith A, Scher H, Scardino P, Reuter V, Gerald WL. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res 2002; 62: 4499-506. (Pubitemid 34827314)
28. Mehra R, Tomlins SA, Shen R et al. Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. Mod Pathol 2007; 20: 538-44. (Pubitemid 46631996)